Interdependent Impact of Lipoprotein Receptors and Lipid-Lowering Drugs on HCV Infectivity

Zapatero-Belinchon, FJ; Otjengerdes, R; Sheldon, J; Schulte, B; Carriqui-Madronal, B; Brogden, G; Arroyo-Fernandez, LM; Vondran, FWR; Maasoumy, B; von Hahn, T; Gerold, G

Gerold, G (corresponding author), TWINCORE, Inst Expt Virol, Ctr Expt & Clin Infect Res, D-30625 Hannover, Germany.; von Hahn, T (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany.; Gerold, G (corresponding author), Umea Univ, Dept Clin Microbiol, Virol, SE-90185 Umea, Sweden.; Gerold, G (corresponding author), Umea Univ, Wallenberg Ctr Mol Med WCMM, SE-90185 Umea, Sweden.; Gerold, G (corresponding author), Univ Vet Med Hannover, Dept Bio

CELLS, 2021; 10 (7):

Abstract

The HCV replication cycle is tightly associated with host lipid metabolism: Lipoprotein receptors SR-B1 and LDLr promote entry of HCV, replication is ......

Full Text Link